Skip to main content

Mark Nelson, Barbara Alving

Mark Nelson has joined Cognia as an advisor and investor. Nelson founded Ovid, a software company that integrates scientific journals, in 1988. The company was sold to Wolters-Kluwers in 1998.

The National Institutes of Health has named Barbara Alving as director of the National Center for Research Resources. Alving was previously acting director of NCRR, a position she has held since 2005. She has been at the NIH since 1999, when she joined the National Heart, Lung, and Blood Institute as the director of the division of blood diseases and resources. She later served as NHLBI deputy director and acting director.

Filed under

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.